HR Execs on the Move

Recursion

www.recursion.com

 
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease. Recursion applies causative perturbations to human cells to generate disease models and associated biological image data. Recursion`s rich, relatable database of more than a petabyte of biological images generated in-house on the company`s robotics platform enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics to radically improve lives. ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.recursion.com
  • 41 S Rio Grande Street
    Salt Lake City, UT USA 84101
  • Phone: 385.269.0203

Executives

Name Title Contact Details
Jace Stoker
 Associate Director of Procurement and Profile
Janelle Gordon
 VP of People Operations Profile
Daniel Benavides
 Director, Talent Acquisition Operations Profile
Lina Nilsson
 Vice President of Product Profile
Lindsay Foot Ellinger
 Sr. Director of Procurement Profile

Similar Companies

Western Slope Labs

Western Slope Labs is a Troy, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Total Joint Orthopedics

Total Joint Orthopedics (TJO) makes high-quality, efficient implants for hip and knee replacement. Our streamlined instrumentation is intuitive and easy to use for reproducible results.

Karyopharm

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm`s SINE compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm`s lead compound, XPOVIO™ (selinexor), received accelerated approval from the FDA in July 2019 in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. A Marketing Authorization Application for selinexor is also currently under review by the European Medicines Agency. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development.

Bioniche Pharma USA

Bioniche Pharma USA LLC is a Lake Forest, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

VioQuest Pharmaceuticals

VioQuest Pharmaceuticals is a Basking Ridge, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.